ECRs: Start your Publishing Career with our new Open Access journal, Neuroretina!
Published in Neuroscience, Biomedical Research, and General & Internal Medicine
Are you an early‑career researcher or clinician working at the intersection of ophthalmology and neuroscience? Neuroretina, Springer Nature’s dedicated journal for translational and clinical research on retinal diseases, is now open for submissions - and this is the perfect moment to share your work!
We’re excited to announce the launch of our brand-new themed collection, 'Oculomics in Neurodegenerative Disease: From Biomarkers to Early Diagnosis', showcasing how ocular biomarkers - whether structural, vascular, proteinopathy, functional, or molecular - can aid in the early detection, disease stratification, and progression monitoring of neurodegenerative disorders. Research focusing on the development of machine learning models, longitudinal imaging studies, comparative biomarker studies, and cross-disciplinary applications is especially encouraged. Find out more here.
Full APC Waivers for Suitable Submissions
To support early-career practitioners and researchers, we’re offering full Article Processing Charge waivers for papers that meet our scope and quality criteria. We know how crucial accessible publishing pathways are in the first stages of your academic career - this is our way of helping your work reach the global community without barriers.
A Diverse, International, and Highly Respected Editorial Board
Our editorial board brings together leading clinicians, surgeons, and scientists from across the world - experts who are shaping the field and championing new voices in research. Their expertise spans retina‑focused neuroscience, imaging innovation, surgical advances, and translational breakthroughs. With such a broad lens, your work will receive thoughtful, rigorous, and field‑relevant evaluation.
Be Part of the Next Wave of Retinal Research
If you’re working on a novel dataset, an innovative technique, or a translational insight that brings the bench closer to the bedside, we want to hear from you. Our new collection is the ideal home for high-quality original research, reviews, and short communications from rising voices in the field.
👉 Explore the journal and submit your manuscript:
https://link.springer.com/journal/44448
If you’re unsure whether your work fits the scope - or want to know more about eligibility for APC waivers - feel free to reach out. We’re here to support you at every step of your publishing journey.
Publish with Neuroretina. Advance the science. Shape the future of retinal health.
Follow the Topic
-
Neuroretina
This is a brand new open access journal, with a focus on using retinal imaging techniques alongside molecular and genetic markers to improve the understanding, diagnosis, and management of neurodegenerative diseases.
-
A Collection of original research articles on the interface between ophthalmology, neurology, and data science.
Your space to connect: The Psychedelics Hub
A new Communities’ space to connect, collaborate, and explore research on Psychotherapy, Clinical Psychology, and Neuroscience!
Continue reading announcement
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in
@Catarina Ferreira
Thank you for this promising announcement and your initiative to support early career researchers.
I am currently working on groundbreaking research in consciousness and neuro ontology that may interest the Neuroretina community and those in translational neuroscience.
The B Bouzid Model offers a new framework for understanding consciousness not as a brain product, but as a function of integration between Sovereignty (F) and Bedrock (B).
The model is applied to neuro dissociative states (like sleep paralysis, sleepwalking) and serves as a foundation for a measurable neuro-ontology, potentially useful for understanding conscious aspects of neurodegenerative disorders.
The paper is freely available here:
· Zenodo: https://zenodo.org/records/18376847
· Academia.edu: https://www.academia.edu/150294875
I welcome any interdisciplinary dialogue around these ideas.